C07D 405/04
Directly linked by a ring-member-to-ring-member bond
Official title: directly linked by a ring-member-to-ring-member bond
C07D405/04 (Directly linked by a ring-member-to-ring-member bond) appears on 4,893 US grants and 5,263 published applications in this corpus.
Search patents in C07D- Granted patents
- 4,893
- Published applications
- 5,263
- Assignees
- 1,825
- Inventors
- 15,406
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 26 | 0 |
| 1977 | 18 | 0 |
| 1978 | 13 | 0 |
| 1979 | 4 | 0 |
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 6 | 0 |
| 1983 | 7 | 0 |
| 1984 | 21 | 0 |
| 1985 | 39 | 0 |
| 1986 | 36 | 0 |
| 1987 | 50 | 0 |
| 1988 | 27 | 0 |
| 1989 | 39 | 0 |
| 1990 | 67 | 0 |
| 1991 | 83 | 0 |
| 1992 | 76 | 0 |
| 1993 | 74 | 0 |
| 1994 | 71 | 0 |
| 1995 | 94 | 0 |
| 1996 | 93 | 0 |
| 1997 | 117 | 0 |
| 1998 | 88 | 0 |
| 1999 | 76 | 0 |
| 2000 | 111 | 0 |
| 2001 | 70 | 16 |
| 2002 | 110 | 82 |
| 2003 | 92 | 150 |
| 2004 | 77 | 229 |
| 2005 | 93 | 193 |
| 2006 | 92 | 185 |
| 2007 | 105 | 190 |
| 2008 | 103 | 161 |
| 2009 | 115 | 199 |
| 2010 | 158 | 231 |
| 2011 | 128 | 204 |
| 2012 | 169 | 192 |
| 2013 | 164 | 188 |
| 2014 | 189 | 235 |
| 2015 | 196 | 261 |
| 2016 | 183 | 272 |
| 2017 | 229 | 264 |
| 2018 | 197 | 234 |
| 2019 | 189 | 231 |
| 2020 | 178 | 246 |
| 2021 | 159 | 217 |
| 2022 | 154 | 256 |
| 2023 | 113 | 268 |
| 2024 | 142 | 226 |
| 2025 | 147 | 201 |
| 2026 | 98 | 132 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Compounds, compositions, and methods for modulating calcium ion homeostasis8 Sep 2026US 12,729,181 B2The Regents of the University of California
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Organic electroluminescent compound, a plurality of host materials, and organic electroluminescent device comprising the same8 Oct 2026US 2026/0314256 A1
- Compounds for treating cancer1 Oct 2026US 2026/0297066 A1Genesis Molecular AI, Inc.
- Electronic device1 Oct 2026US 2026/0305163 A1Merck Patent GmbH
- Butenolide-based estrogen receptor alpha inhibitors and degraders and method of using the same24 Sep 2026US 2026/0285824 A1Georgia Tech Research Corporation
Most cited
By later US patents
- Backbone modified oligonucleotide analogs983US 5,602,240 ACiba-Geigy Corporation · 1997
- Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms772US 5,489,677 AIsis Pharmaceuticals, Inc. · 1996
- Conjugated 4'-desmethyl nucleoside analog compounds660US 5,608,046 AIsis Pharmaceuticals, Inc. · 1997
- Pyrimidine derivatives for labeled binding partners639US 5,502,177 AGilead Sciences, Inc. · 1996
- Backbone modified oligonucleotide analogues637US 5,610,289 AIsis Pharmaceuticals, Inc. · 1997